The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Role of complement in neurodegeneration and neuroinflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 884
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
über eigenartige Krankheitsfälle des späteren Alters
Alzheimer, A. (1911) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02866241 · Cited by 710
Inflammation and neurodegeneration in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 625
The lectin‐complement pathway – its role in innate immunity and evolution
Fujita, T., Matsushita, M., & Endo, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0123.x · Cited by 606
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H., & Lachmann, P. J. (1990) · PubMed Central · Cited by 533
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Landles, C., & Bates, G. P. (2004) · EMBO reports · doi:10.1038/sj.embor.7400250 · Cited by 488
C1q: Structure, function, and receptors
Kishore, U., & Reid, K. B. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80301-x · Cited by 479
Self-citationProminent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
C1q and tumor necrosis factor superfamily: modularity and versatility
Kishore, U., Gaboriaud, C., Waters, P., Shrive, A. K., Greenhough, T. J., Reid, K. B. M., Sim, R. B., & Arlaud, G. J. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.08.006 · Cited by 436
Self-citationPresenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
Zhang, Z., Nadeau, P., Song, W., Donoviel, D., Yuan, M., Bernstein, A., & Yankner, B. A. (2000) · Nature Cell Biology · doi:10.1038/35017108 · Cited by 409
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampel, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382
Brown, K. L., Stewart, K., Ritchie, D. L., Mabbott, N. A., Williams, A., Fraser, H., Morrison, W. I., & Bruce, M. E. (1999) · Nature Medicine · doi:10.1038/15264 · Cited by 363
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
Cox, P. A., & Sacks, O. W. (2002) · Neurology · doi:10.1212/wnl.58.6.956 · Cited by 329
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65340-0 · Cited by 327
Complement facilitates early prion pathogenesis
Klein, M. A., Kaeser, P. S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R. M., Carroll, M. C., Verbeek, J. S., Botto, M., Walport, M. J., et al. (2001) · Nature Medicine · doi:10.1038/86567 · Cited by 318
Singhrao, S. K., Neal, J. W., Morgan, B. P., & Gasque, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7170 · Cited by 316
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303
Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
Copeland, J. R. M., Davidson, I. A., Dewey, M. E., Gilmore, C., Larkin, B. A., Mcwilliam, C., Saunders, P. A., Scott, A., Sharma, V., & Sullivan, C. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.2.230 · Cited by 293
Xia, M., Qin, S., Wu, L., Mackay, C. R., & Hyman, B. T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65542-3 · Cited by 292
Heneka, M. T., Galea, E., Gavriluyk, V., Dumitrescu-Ozimek, L., Daeschner, J., O'Banion, M. K., Weinberg, G., Klockgether, T., & Feinstein, D. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02434.2002 · Cited by 259
Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
Mackenzie, I. R. A., & Munoz, D. G. (1998) · Neurology · doi:10.1212/wnl.50.4.986 · Cited by 244
Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J., & Pepys, M. B. (2001) · Nature Medicine · doi:10.1038/86562 · Cited by 224
Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins
Meda, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00307-4 · Cited by 222
McBride, P. A., Eikelenboom, P., Kraal, G., Fraser, H., & Bruce, M. E. (1992) · The Journal of Pathology · doi:10.1002/path.1711680412 · Cited by 219
Carmichael, J., Chatellier, J., Woolfson, A., Milstein, C., Fersht, A. R., & Rubinsztein, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170280697 · Cited by 211
Levites, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25410 · Cited by 207
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206
Inflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Structural and functional anatomy of the globular domain of complement protein C1q
Kishore, U., Ghai, R., Greenhough, T. J., Shrive, A. K., Bonifati, D. M., Gadjeva, M. G., Waters, P., Kojouharova, M. S., Chakraborty, T., & Agrawal, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.015 · Cited by 195
Self-citationNeuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
Shen, Y., Li, R., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 195
In vivo detection of microglial activation in frontotemporal dementia
Cagnin, A., Rossor, M., Sampson, E. L., MacKinnon, T., & Banati, R. B. (2004) · Annals of Neurology · doi:10.1002/ana.20332 · Cited by 187
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 185
Tacnet‐Delorme, P., Chevallier, S., & Arlaud, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6374 · Cited by 162
Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer, P. L., & McGeer, E. G. (1998) · PubMed · Cited by 158
Jeffrey, M., McGovern, G., Goodsir, C. M., L Brown, K., & Bruce, M. E. (2000) · The Journal of Pathology · doi:10.1002/1096-9896(200007)191:3<323::aid-path629>3.0.co;2-z · Cited by 158
Amyloid-β-induced chemokine production in primary human macrophages and astrocytes
Smits, H. A., Rijsmus, A., van Loon, J. H., Wat, J. W. Y., Verhoef, J., Boven, L. A., & Nottet, H. S. L. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00112-1 · Cited by 153
Characterization of the microglial response in murine scrapie
Williams, A. E., Lawson, L. J., Perry, V. H., & Fraser, H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00956.x · Cited by 151
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
O’Barr, S. A., Caguioa, J., Gruol, D. L., Perkins, G. A., Ember, J. A., Hugli, T. E., & Cooper, N. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4154 · Cited by 149
Neurons express proteins of the classical complement pathway in Alzheimer disease.
Terai, K., Walker, D., Mcgeer, E., & McGeer, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00849-4 · Cited by 149
The membrane attack complex of complement induces caspase activation and apoptosis
Nauta, A. J., Daha, M. R., Tijsma, O., van de Water, B., Tedesco, F., & Roos, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<783::aid-immu783>3.0.co;2-q · Cited by 148
Yang, L., Li, R., Meri, S., Rogers, J., & Shen, Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07505.2000 · Cited by 135
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 127
Role of Complement in the Induction of Immunological Responses
Pepys, M. B. (1976) · Immunological Reviews · doi:10.1111/j.1600-065x.1976.tb00230.x · Cited by 126
Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., & Bruce, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3338-3344.2000 · Cited by 126
Członkowska, A., Kurkowska‐Jastrzębska, I., Członkowski, A., Peter, D., & Stefano, G. B. (2002) · PubMed · Cited by 124
Soane, L., Cho, H.-J., Niculescu, F. I., Rus, H., & Shin, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2305 · Cited by 122
Genetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 120
Guan, E., Robinson, S. L., Goodman, E. B., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4005 · Cited by 119
Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains
Kishore, U., Gupta, S. K., Perdikoulis, M. V., Kojouharova, M. S., Urban, B. C., & Reid, K. B. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.812 · Cited by 119
Self-citationDetection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 117
Klein, A., Kowall, N. W., & Ferrante, R. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07845.x · Cited by 115
Pasinetti, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00113-3 · Cited by 115
Soane, L., Rus, H., Niculescu, F. I., & Shin, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6132 · Cited by 113
C3 Requirements for Formation of Alternative Pathway C5 Convertase
Daha, M. R., Fearon, D. T., & Austen, K. F. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.117.2.630 · Cited by 110
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 110
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
van Beek, J., Nicole, O., Ali, C., Ischenko, A. M., MacKenzie, E. T., Buisson, A., & Fontaine, M. (2001) · Neuroreport · doi:10.1097/00001756-200102120-00022 · Cited by 110
Notch and the Amyloid Precursor Protein Are Cleaved by Similar γ-Secretase(s)
Kimberly, W. T., Esler, W. P., Ye, W., Ostaszewski, B. L., Gao, J., Diehl, T. S., Selkoe, D. J., & Wolfe, M. S. (2002) · Biochemistry · doi:10.1021/bi026888g · Cited by 107
The role of complement in the acquired immune response
Nielsen, C. H., Fischer, E., & Leslie, R. G. Q. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00009.x · Cited by 106
Haas, J., Storch-Hagenlocher, B., Biessmann, A., & Wildemann, B. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00095-2 · Cited by 105
Head, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 104
OʼKusky, J. R., Nasir, J., Cicchetti, F., Parent, A., & Hayden, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01312-2 · Cited by 97
Activated Immune System in Patients with Huntington's Disease
Leblhuber, F., Walli, J., Jellinger, K., Tilz, G. P., Widner, B., Laccone, F. A., & Fuchs, D. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.132 · Cited by 89
Arlaud, G. J., Gaboriaud, C., Thielens, N. M., Budayova-Spano, M., Rossi, V., & Fontecilla-Camps, J. C. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00143-8 · Cited by 88
Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease
Abraham, C. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00302-5 · Cited by 87
Webster, S., Glabe, C., & Rogers, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2852 · Cited by 84
The possible role of complement activation in Alzheimer disease
McGeer, P. L., & McGeer, E. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02422-x · Cited by 81
Eikelenboom, P., Rozemüller, A. J. M., Kraal, G., Stam, F. C., McBride, P., Bruce, M. E., & Fraser, H. (1991) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899564 · Cited by 81
Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster, S. M., Bonnell, B. S., & Rogers, J. (1997) · Europe PMC (PubMed Central) · Cited by 77
Farkas, I., Takahashi, M., Fukuda, A., Yamamoto, N., Akatsu, H., Baranyi, L., Tateyama, H., Yamamoto, T., Okada, N., & Okada, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5764 · Cited by 75
Complement activation in human prion disease
Kovács, G. G., Gasque, P., Ströbel, T., Lindeck‐Pozza, E., Strohschneider, M., Ironside, J. W., Budka, H., & Guentchev, M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.010 · Cited by 73
Initiation of C3 Cleavage in the Alternative Complement Pathway
Fearon, D. T., & Austen, K. F. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.5.1357 · Cited by 71
O’Barr, S. A., & Cooper, N. R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00291-5 · Cited by 63
Complement Activation in Chromosome 13 Dementias
Rostagno, A. A., Révész, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Brændgaard, H., Plant, G. T., Bojsen‐Møller, M., Holton, J. L., Frangione, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206448200 · Cited by 63
Schwab, C., Steele, J. C., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01257-5 · Cited by 62
Anti-inflammatory drugs and Alzheimer-type pathology in aging
Mackenzie, I. R. (2000) · Neurology · doi:10.1212/wnl.54.3.732 · Cited by 56
Activation of complement and contact system in Alzheimer's disease
Bergamaschini, L. C., Donarini, C., Gobbo, G. F. D., Parnetti, L., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00311-6 · Cited by 55
Complement Protein C1q Recognizes a Conformationally Modified Form of the Prion Protein
Blanquet-Grossard, F., Thielens, N. M., Vendrely, C., Jamin, M., & Arlaud, G. J. (2005) · Biochemistry · doi:10.1021/bi047370a · Cited by 53
Activated microglial cells and complement factors are unrelated to cortical Lewy bodies
Rozemuller, A. J. M., Eikelenboom, P., Theeuwes, J. W., Jansen Steur, E. N. H., & de Vos, R. A. I. (2000) · Acta Neuropathologica · doi:10.1007/s004010000225 · Cited by 50
Complement-mediated neurotoxicity is regulated by homologous restriction
Shen, Y., Halperin, J. A., & Lee, C. (1995) · Brain Research · doi:10.1016/0006-8993(94)01264-i · Cited by 50
O’Connor, D., Pollitt, P. A., Jones, B. J., Hyde, J. B., Fellowes, J. L., & Miller, N. D. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05509.x · Cited by 46
Luo, X., Weber, G. A., Zheng, J., Gendelman, H. E., & Ikezu, T. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00444-7 · Cited by 45
Histological and biochemical pathology in a family with autosomal dominant Parkinsonism and dementia
Yamada, T., McGeer, E. G., Schelper, R. L., Wszołek, Z. K., McGeer, P. L., Pfeiffer, R. F., & Rodnitzky, R. L. (1993) · Neurology Psychiatry and Brain Research · Cited by 44
Ishii, T., Haga, S., Yagishita, S., & Tateishi, J. (1984) · PubMed · Cited by 42
Oyanagi, K. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.010 · Cited by 39
Wang, W., & Passaniti, A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990601)73:3<303::aid-jcb2>3.0.co;2-2 · Cited by 30
Yamada, T., McGeer, P. L., & McGeer, E. G. (1991) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107179 · Cited by 29
Tooyama, I., Sato, H., Yasuhara, O., Kimura, H., Konishi, Y., Shen, Y., Walker, D. G., Beach, T. G., Sue, L. I., & Rogers, J. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051265 · Cited by 24
INFLAMMATION IN PARKINSON'S DISEASE
Benigno, A., Esposito, E., Crescimanno, G., & Di Giovanni, G. (2007) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 24
Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-β1-42
Bate, C., Veerhuis, R., Eikelenboom, P., & Williams, A. (2003) · Neuroreport · doi:10.1097/00001756-200311140-00018 · Cited by 22
Early complement activation increases in the brain in some aged normal subjects
Loeffler, D. A., Camp, D. M., Schonberger, M. B., Singer, D. J., & LeWitt, P. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.003 · Cited by 19
Schwab, C., Steele, J. C., & McGeer, P. L. (1997) · Acta Neuropathologica · doi:10.1007/s004010050737 · Cited by 18
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
CNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 795
Metadata
- Authors
- BONIFATI, D., & KISHORE, U.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 44
- Issue
- 5
- Pages
- 999-1010
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W2072237144
- Cited by
- 313
- References
- 120
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.